The expression of ACSM3 is significantly reduced in hepatocellular carcinoma tissues and is associated with the late stage and poor survival rates of hepatocellular carcinoma (Boomgaarden et al., 2009). Here, ACSM3 is linked to hepatocellular carcinoma.